Jitters over the health of the UK economy have been fuelled by today’s weaker-than-expected GDP release. September’s 0.1% ...

The latest GDP figures come as a blow to Rachel Reeves, the chancellor, who said she was not "satisfied with the numbers".

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

This is a major concern for Moderna because it could mean that they used a GSK technology to produce their COVID-19 vaccine, Spikevax, as well as their RSV vaccine, mResvia. GSK asserts that ...

The trial’s co-primary endpoints were RSV-A and RSV-B neutralization titers following a first and a second dose of GSK’s RSV vaccine expressed as mean geometric increase post dose 2 relative ...

GSK is delivering consistent financial performance ... The Gardasil royalty loss impacted profit growth by minus 8% this quarter, meaning underlying operating profit was up 13%, demonstrating ...

GlaxoSmithKline Pharma continued to benefit ... since September 2022. * Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell ** Ratio of the stock's ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Phase 3 PIVOT-PO trial of tebipenem HBr remains on track to complete enrollment in 2H 2025Reiterate cash runway into mid-2026; Q3 2024 ending ...